DCGI Waves Green Flag to the Launch of Low-Cost COVID-19 Test ‘Feluda’
THD NewsDesk, NEW DELHI: The DCGI has authorized the commercial launch of 'Feluda', the Tata CRISPR (Clustered Regularly Interspaced Short ...
THD NewsDesk, NEW DELHI: The DCGI has authorized the commercial launch of 'Feluda', the Tata CRISPR (Clustered Regularly Interspaced Short ...
A daily dose of news, views, opinions, and actionable information from the global healthcare industry. Our newsletter is available for a limited audience. If you are interested to write or contribute to this portal then please get in touch.
© 2025 - The Healthcare Daily